Indivior shares tank after U.S. indictment for illegal marketing
Shares of Indivior Plc sank 44 percent on Wednesday after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the film version of its blockbuster opioid addiction treatment Suboxone.
from Reuters: Health News https://reut.rs/2D5N4mC
http://bit.ly/2zwRqiM
April 10, 2019
|
Labels:
health,
Reuters: Health News
|
This entry was posted on April 10, 2019
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.